We are live on
!
Find out more
MHC
Meyer Handelman Company Portfolio holdings
AUM
$3.22B
1-Year Est. Return
24.51%
This Fund
S&P 500
This Quarter
Est. Return
+2.83%
1 Year Est. Return
+24.51%
3 Year Est. Return
+68.19%
5 Year Est. Return
+95.69%
10 Year Est. Return
+272.81%
AUM
$3.19B
AUM Growth
+$31.2M
(+0.99%)
Cap. Flow
-$19.3M
Cap. Flow
% of AUM
-0.6%
Top 10 Holdings %
Top 10 Hldgs %
34.42%
Holding
221
New
7
Increased
37
Reduced
102
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royal Gold
RGLD
|
+$7.14M |
| 2 |
Apple
AAPL
|
+$7.04M |
| 3 |
SOLS
Solstice Advanced Materials
SOLS
|
+$4.63M |
| 4 |
Q
Qnity Electronics Inc
Q
|
+$3.53M |
| 5 |
TSMC
TSM
|
+$3.14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
K
Kellanova
K
|
+$7.11M |
| 2 |
Honeywell
HON
|
+$5.8M |
| 3 |
Omnicom Group
OMC
|
+$5.08M |
| 4 |
DuPont de Nemours
DD
|
+$4.38M |
| 5 |
Avery Dennison
AVY
|
+$4.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.48% |
| 2 | Industrials | 16.75% |
| 3 | Healthcare | 12.8% |
| 4 | Consumer Staples | 10.92% |
| 5 | Financials | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Vertex Pharmaceuticals
VRTX
$121B
| $261K | 0.01% |
+575
| New | +$248K |
|
202
Advanced Micro Devices
AMD
$799B
| $249K | 0.01% |
+1,162
| New | +$261K |
|
203
Elevance Health
ELV
$81.9B
| $245K | 0.01% |
700
| – | – |
|
204
Wabtec
WAB
$49.6B
| $240K | 0.01% |
1,125
| – | – |
|
|
EXAS
205
DELISTED
Exact Sciences
EXAS
| $239K | 0.01% |
+2,350
| New | +$189K |
|
206
Schwab US Large-Cap Growth ETF
SCHG
$59.6B
| $231K | 0.01% |
7,096
| – | – |
|
207
Keysight
KEYS
$55.1B
| $229K | 0.01% |
+1,125
| New | +$209K |
|
208
Comcast
CMCSA
$85B
| $221K | 0.01% |
7,404
| – | – |
|
|
SCHW
209
Charles Schwab
SCHW
$183B
| $220K | 0.01% |
2,200
-292
| -12% | -$27.7K |
|
210
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
| $214K | 0.01% |
3,644
| – | – |
|
211
Linde
LIN
$221B
| $211K | 0.01% |
496
+46
| +10% | +$19.7K |
|
|
CYBR
212
DELISTED
CyberArk
CYBR
| $201K | 0.01% |
450
| – | – |
|
213
Elicio Therapeutics
ELTX
$74.1M
| $111K | ﹤0.01% |
13,899
| – | – |
|
214
Pitney Bowes
PBI
$2.35B
| $106K | ﹤0.01% |
10,000
| – | – |
|
215
Arthur J. Gallagher & Co
AJG
$64.9B
| – | – |
-1,131
| Closed | -$350K |
|
216
Devon Energy
DVN
$51.4B
| – | – |
-15,701
| Closed | -$550K |
|
|
FISV
217
Fiserv Inc
FISV
$28.6B
| – | – |
-2,400
| Closed | -$309K |
|
218
Haleon
HLN
$43.5B
| – | – |
-17,169
| Closed | -$154K |
|
|
K
219
DELISTED
Kellanova
K
| – | – |
-86,700
| Closed | -$7.11M |
|
220
Oracle
ORCL
$370B
| – | – |
-900
| Closed | -$253K |
|
221
Solventum
SOLV
$14.8B
| – | – |
-3,736
| Closed | -$273K |
|
Similar funds
EWA
SYBT
RPGK
KIM
YCM
SC
HCM
BIG
Meyer Handelman Company's Q4 2025 Portfolio in Review
As of Q4 2025, Meyer Handelman Company held 221 positions worth $3.19B, up 0.99% from $3.16B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Meyer Handelman Company's Q4 2025 filing shows 7 new, 37 increased, 102 reduced and 7 closed positions. Its largest new stake was Royal Gold: 36,008 shares worth $8M. The largest sale was Kellanova, an estimated $7.11M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Industrials and Healthcare.
- Meyer Handelman Company's largest Q4 2025 buy was Royal Gold: 36,008 shares worth $8M.
- Meyer Handelman Company added most to Apple in Q4 2025, an estimated $7.04M increase.
- Meyer Handelman Company's biggest Q4 2025 reduction was Honeywell, cutting an estimated $5.8M.
- Meyer Handelman Company fully exited Kellanova in Q4 2025, selling an estimated $7.11M.
- Meyer Handelman Company's ten largest holdings make up 34% of its $3.19B portfolio in Q4 2025.
- Meyer Handelman Company opened 7 new positions and closed 7 in Q4 2025.
- Meyer Handelman Company's portfolio value rose 0.99% quarter-over-quarter to $3.19B.
Based on Meyer Handelman Company's 13F filing for Q4 2025, filed 15 Jan 2026.